<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753567</url>
  </required_header>
  <id_info>
    <org_study_id>00127554</org_study_id>
    <nct_id>NCT04753567</nct_id>
  </id_info>
  <brief_title>nCap Pain Relief Patch vs. Placebo</brief_title>
  <official_title>nCap Medical Nano-Capacitive Pain Relief Patch vs Placebo, a Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>nCap Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>nCap Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether use of the nCap Medical Nano-Capacitive&#xD;
      pain relief patch reduces subject pain as measured by subject pain scores, WOMAC scores&#xD;
      (pain, stiffness and physical function), global assessment scores, and pain medication change&#xD;
      as compared to participants randomly assigned to the sham patch group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score using VAS scale</measure>
    <time_frame>After 30 minutes of use</time_frame>
    <description>0-10 pain scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WOMAC score</measure>
    <time_frame>3 weeks</time_frame>
    <description>arthritis assessment score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sustained pain response</measure>
    <time_frame>3 weeks</time_frame>
    <description>0-10 VAS pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global assessment question</measure>
    <time_frame>3 weeks</time_frame>
    <description>How the patient feels they are doing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication monitoring</measure>
    <time_frame>3 weeks</time_frame>
    <description>Tylenol use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Actual pain patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham patch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nCap pain relief patch</intervention_name>
    <description>Each participant will be randomly assigned to sham or actual patch. Patches will be worn for 3 weeks. Pain and quality of life will be assessed and compared between groups</description>
    <arm_group_label>Actual pain patch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Patch</intervention_name>
    <description>Sham patch will be worn for 3 weeks exactly like actual pain patch</description>
    <arm_group_label>Sham patch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meet Altman's clinical criteria for Knee Osteoarthritis&#xD;
&#xD;
          -  Male and Female Adults age 40-79&#xD;
&#xD;
          -  VAS pain score of &gt; 4 at the beginning of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject unable to walk unassisted. Participants must be able to stand/walk for 30&#xD;
             minutes&#xD;
&#xD;
          -  Inability to read and understand English. Must be able to complete WOMAC scale and&#xD;
             questionnaires&#xD;
&#xD;
          -  Severe systemic disease limiting ability to ambulate for 30 minutes&#xD;
&#xD;
          -  Use of a TENS unit for one week before study or during study&#xD;
&#xD;
          -  History of total knee replacement on the affected knee&#xD;
&#xD;
          -  Knee surgery on the affected knee in the last 12 months&#xD;
&#xD;
          -  Injection into the knee in the last 6 months&#xD;
&#xD;
          -  Knee pain &lt; 411&#xD;
&#xD;
          -  Inability to cognitively understand consent form or research study, or inability to&#xD;
             give consent&#xD;
&#xD;
          -  Diagnosis of fibromyalgia, rheumatoid arthritis, gout, dysplasia, septic arthritis,&#xD;
             knee pain from other diseases.&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Injury to knee within 6 months&#xD;
&#xD;
          -  Concomitant use of opioids, NSAIDS or other analgesics for 1 week before trial (or 5&#xD;
             half-lives, whichever is greater)9, or during trial with exception of acetaminophen.&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Poor general health (ASA classification of IV+)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tatjana Warren, PhD CRNA</last_name>
    <phone>8584051003</phone>
    <email>tsbevans@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Knee Arthritis Clinical Trial Officew</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatjana Warren, PhD</last_name>
      <phone>801-970-2577</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 9, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain, arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

